e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Different profiles of sarcoidosis and other granulomatous disorders
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of infliximab on lung function and well-being in patients with refractory sarcoidosis
H. N. A. J. van Rijswijk, A. D. M. Vorselaars, I. H. E. Korenromp, H. J. T. Ruven, R. G. M. Keijsers, J. C. Grutters (Nieuwegein, ‘s Hertogenbosch, Utrecht, Netherlands)
Source:
Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Session:
Different profiles of sarcoidosis and other granulomatous disorders
Session type:
Thematic Poster Session
Number:
3720
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. N. A. J. van Rijswijk, A. D. M. Vorselaars, I. H. E. Korenromp, H. J. T. Ruven, R. G. M. Keijsers, J. C. Grutters (Nieuwegein, ‘s Hertogenbosch, Utrecht, Netherlands). Effect of infliximab on lung function and well-being in patients with refractory sarcoidosis. Eur Respir J 2011; 38: Suppl. 55, 3720
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effects of infliximab on systemic features in patients with COPD suffering from cachexia
Source: Eur Respir J 2006; 28: Suppl. 50, 105s
Year: 2006
The effect of prednisone treatment on lung function test parameters in patients with chronic sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 433s
Year: 2002
Effects of infliximab on local and systemic inflammation in patients with COPD suffering from cachexia
Source: Eur Respir J 2006; 28: Suppl. 50, 105s
Year: 2006
Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: management
Year: 2010
Effect of ABPA treatment in severe asthma patients with acute and relapsed disease
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Long-term treatment with infliximab in patients with sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Efficacy of pulmonary rehabilitation in patients with interstitial lung disease
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
Effects of pulmonary rehabilitation on systemic inflammation in patients with advanced COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 721s
Year: 2005
Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function
Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Year: 2020
Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function
Source: Eur Respir J 2016; 48: 843-851
Year: 2016
Compliance with nebulized therapy in patients with chronic lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 59s
Year: 2001
Long-term response to prednisone in newly treated patients with pulmonary sarcoidosis
Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Year: 2021
Effect of bronchodilator therapy on the quality of life of pulmonary TB patients
Source: Eur Respir J 2002; 20: Suppl. 38, 442s
Year: 2002
Effect of metformin on clinically relevant outcomes in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Effect of inhaled bronchodilator therapy on the bacterioexcretion and on the quality of life (LQ) of pulmonary TB patients with concomitant lung obstructive syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006
ACE and sIL2-R predict lung function improvement in sarcoidosis during methotrexate therapy
Source: Annual Congress 2013 –Sarcoidosis
Year: 2013
The course of COVID-19 in pulmonary sarcoidosis patients, receiving methotrexate
Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis
Year: 2021
Effects of helium/oxygen therapy on QoL in lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 455s
Year: 2002
Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Effect of low dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real life study
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept